- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
3. In the table in Schedule 3A to the principal Order(1) (substances which may be prescribed, administered or directed for administration by extended formulary nurse prescribers and conditions for such prescription or administration)—
(a)for the entry for “Erythromycin”, in column 2, after “External Use” insert “or oral”;
(b)for the entry “Fusidic acid”, in column 2 for “Opthalmic Use” substitute “External Use”;
(c)for the entry “Hycosine butylbromide”, in column 2, after “parenteral” insert “or transdermal”;
(d)for the entry “Hycosine hydrobromide”, in column 2, for “Oral, parenteral or transdermal administration in palliative care” substitute “Oral or parenteral administration in palliative care”;
(e)for the entry “Metronidazole”, in column 2 for “External use or oral” substitute “External use, oral or rectal”;
(f)for the entry “Prednisolone sodium phosphate”, in column 2, after “Aural” insert “or oral”;
(g)in column 1 insert, at the appropriate place in the alphabetical order of the entries as they appear in that column, each of the entries set out in column 1 below, and in column 2 insert, against those entries, the corresponding entries in column 2 below—
Column 1 | Column 2 |
---|---|
Amitriptyline hydrochloride | Oral |
Azithromycin dihydrate | Oral |
Carbamazepine | Oral or rectal |
Clavulanic acid | Oral |
Conjugated oestrogens (equine) | External use |
Diclofenac potassium | Oral |
Diclofenac sodium | Oral or rectal |
Erythromycin ethyl succinate | Oral |
Erythromycin stearate | Oral |
Estradiol | External use |
Estriol | External use |
Etonogestrel | Implant |
Flumazenil | Parenteral |
Gabapentin | Oral |
Glucagon hydrochloride | Parenteral |
Glucose | Parenteral |
Imipramine hydrochloride | Oral |
Lignocaine hydrochloride | External use or parenteral |
Lymecycline | Oral |
Nortriptyline hydrochloride | Oral |
Prednisolone | Oral |
Salbutamol sulphate | Inhalation |
Sodium fusidate | External use |
Terbutaline sulphate | Inhalation |
Schedule 3A was inserted by SI 2002/549, and amended by SI 2003/696 and 2915.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: